What was the market valuation of the vascular embolization market in 2024?

The market valuation was $52.2 Million in 2024. Read More

What is the projected market valuation for 2035?

The projected market valuation for 2035 is $147.25 Million. Read More

What is the expected CAGR for the vascular embolization market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 9.89%. Read More

What are the two main segments of the vascular embolization market?

The two main segments are Technique and Application. Read More

What was the valuation of coiling devices in the vascular embolization market?

The valuation of coiling devices was $20.88 Million in 2024 and is projected to reach $56.25 Million by 2035. Read More

What is the projected valuation for non-coiling devices by 2035?

The projected valuation for non-coiling devices is $91.0 Million by 2035. Read More

Which application segment had the highest valuation in 2024?

The Oncology application segment had the highest valuation at $15.0 Million in 2024. Read More

What is the projected valuation for the Peripheral Vascular Disease application by 2035?

The projected valuation for the Peripheral Vascular Disease application is $30.0 Million by 2035. Read More

How does the market for vascular embolization appear to be evolving in South Korea?

The market appears to be evolving positively, with a projected growth trajectory leading to a valuation of $147.25 Million by 2035. Read More

South Korea Vascular Embolization Market

Q: Which companies are considered key players in the vascular embolization market?

Key players include Medtronic, Boston Scientific, Terumo Corporation, Johnson & Johnson, Stryker Corporation, B. Braun Melsungen AG, Cook Medical, Abbott Laboratories, and AngioDynamics. Read More

ID: MRFR/HC/50294-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

South Korea Vascular Embolization Market Research Report: Size, Share, Trend Analysis By Embolization Technique (Coiling Devices, Non-coiling Devices) and By Applications (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Vascular Embolization Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.89%

2024 Market Size$ 52.2 Million

2025 Market Size$ 57.37 Million

2035 Market Size$ 147.25 Million

Key Players

Medtronic

Boston Scientific

Terumo Corporation

Johnson & Johnson

Stryker Corporation

B. Braun Melsungen AG

Trends

Technological Advancements
Rising Incidence of Vascular Diseases
Regulatory Support for Innovation

Opportunities

Aging Population
Increasing Healthcare Expenditure
Supportive Regulatory Environment

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Technique (USD Million)
  1. 4.1.1 Coiling Devices
  2. 4.1.2 Non-coiling Devices
2. 4.2 Life Sciences, BY Application (USD Million)
  1. 4.2.1 Peripheral Vascular Disease
  2. 4.2.2 Oncology
  3. 4.2.3 Neurology
  4. 4.2.4 Urology
  5. 4.2.5 Other
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Terumo Corporation (JP)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Stryker Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 B. Braun Melsungen AG (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cook Medical (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Abbott Laboratories (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 AngioDynamics (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY TECHNIQUE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
4. 6.4 KEY BUYING CRITERIA OF LIFE SCIENCES
5. 6.5 RESEARCH PROCESS OF MRFR
6. 6.6 DRO ANALYSIS OF LIFE SCIENCES
7. 6.7 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
8. 6.8 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
9. 6.9 SUPPLY / VALUE CHAIN: LIFE SCIENCES
10. 6.10 LIFE SCIENCES, BY TECHNIQUE, 2024 (% SHARE)
11. 6.11 LIFE SCIENCES, BY TECHNIQUE, 2024 TO 2035 (USD Million)
12. 6.12 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNIQUE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Life Sciences Market Segmentation

Life Sciences By Technique (USD Million, 2025-2035)

Coiling Devices
Non-coiling Devices

Life Sciences By Application (USD Million, 2025-2035)

Peripheral Vascular Disease
Oncology
Neurology
Urology
Other

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”